GO:0006418 tRNA aminoacylation for protein translation: Protein Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006418 (tRNA aminoacylation for protein translation) is the biological process that attaches amino acids to their cognate tRNAs via an ester bond, forming aminoacyl-tRNA for ribosomal protein synthesis.
• Aminoacyl-tRNA synthetases (ARSs) catalyze this reaction with high fidelity, using identity elements in tRNA to ensure correct pairing.
• The process is essential for translation and is targeted by antibiotics and explored for drug development.
• Dysregulation of tRNA aminoacylation is linked to cancer, neurological disorders, and mitochondrial diseases [1,6].
• Engineered tRNA aminoacylation enables genetic code expansion and noncanonical amino acid incorporation [5,6].
• Research methods include spectrophotometric assays, tRNA-Seq, and genetic screens to measure aminoacylation levels [7,8].
Description
tRNA aminoacylation for protein translation (GO:0006418) is the essential biological process that charges transfer RNAs with their corresponding amino acids, forming aminoacyl-tRNAs that deliver amino acids to the ribosome for protein synthesis. This process ensures the faithful translation of the genetic code and is catalyzed by aminoacyl-tRNA synthetases (ARSs), a family of enzymes that activate amino acids and attach them to the 3'-end of tRNAs. The reaction proceeds in two steps: amino acid activation with ATP to form an aminoacyl-adenylate, followed by transfer of the amino acid to the tRNA's terminal adenosine. The specificity of this process is critical for cellular viability, and errors can lead to mistranslation and proteotoxicity. Beyond its fundamental role, tRNA aminoacylation is a target for antibiotic development and a tool for expanding the genetic code in synthetic biology [2,5]. Researchers study this process to understand translation regulation, disease mechanisms, and to engineer novel biotherapeutics.
tRNA aminoacylation for protein translation At A Glance
| GO ID | GO:0006418 |
|---|---|
| GO term | tRNA aminoacylation for protein translation |
| Ontology | biological_process |
| Synonym | None |
| Major function | Attachment of amino acids to tRNAs for protein synthesis |
| Key enzymes | Aminoacyl-tRNA synthetases (ARSs) |
| Cellular location | Cytoplasm and mitochondria |
| Pathway | Translation |
| Disease relevance | Cancer, neurological disorders, mitochondrial diseases |
What Is GO:0006418?
tRNA aminoacylation for protein translation is the synthesis of an aminoacyl-tRNA through the formation of an ester bond between the 3'-hydroxyl group of the most 3' adenosine of a tRNA molecule and the alpha-carboxylic acid group of an amino acid. This charged tRNA is then used in ribosome-mediated polypeptide synthesis.
Why Is tRNA aminoacylation for protein translation Important in Cell Biology?
tRNA aminoacylation is fundamental to all living organisms because it provides the charged tRNAs necessary for ribosomal protein synthesis. Without accurate aminoacylation, translation would be error-prone, leading to dysfunctional proteins and cellular stress. This process is also a hub for cellular regulation, integrating amino acid availability with translation rates via signaling pathways such as mTOR. Moreover, mutations in ARSs cause a range of human diseases, including Charcot-Marie-Tooth disease and mitochondrial disorders, making this process a key area of biomedical research [2,6].
• Essential for protein synthesis and cell viability.
• Ensures translational fidelity through proofreading by ARSs.
• Target for antibiotics and anti-parasitic drugs.
• Linked to cancer through oncogenic transformation and metabolic reprogramming.
• Implicated in neurological disorders such as Charcot-Marie-Tooth disease.
• Enables genetic code expansion for synthetic biology and therapeutics.
• Regulated by nutrient signaling pathways like mTOR.
• Dysregulation leads to mitochondrial dysfunction and disease.
• Provides a mechanism for cellular stress response via amino acid sensing.
• Key for understanding translation regulation in development and disease.
What Happens During tRNA aminoacylation for protein translation?
Amino Acid Activation
In simple terms: The enzyme first attaches the amino acid to AMP using ATP, creating an activated intermediate.
In the first step of tRNA aminoacylation, an aminoacyl-tRNA synthetase (ARS) binds a specific amino acid and ATP, catalyzing the formation of an aminoacyl-adenylate intermediate with the release of pyrophosphate. This activation step is essential for the subsequent transfer of the amino acid to the tRNA.
tRNA Binding and Recognition
In simple terms: The enzyme recognizes the correct tRNA through specific molecular features.
ARSs recognize their cognate tRNAs via identity elements, which are specific nucleotides often located in the acceptor stem, anticodon loop, and other regions. This recognition ensures that only the correct tRNA is charged with the corresponding amino acid, maintaining translational fidelity.
Ester Bond Formation
In simple terms: The amino acid is transferred to the tRNA, forming a high-energy ester bond.
The activated amino acid is transferred to the 3'-hydroxyl group of the terminal adenosine of the tRNA, forming an aminoacyl-tRNA with an ester bond. This reaction is catalyzed by the same ARS and results in a charged tRNA ready for translation.
Proofreading and Editing
In simple terms: Some enzymes double-check their work to prevent attaching the wrong amino acid.
To maintain high fidelity, many ARSs possess editing domains that hydrolyze incorrectly formed aminoacyl-adenylates or mischarged tRNAs. This proofreading activity is crucial for preventing mistranslation and cellular stress.
Delivery to the Ribosome
In simple terms: The charged tRNA is delivered to the ribosome to add its amino acid to a growing protein chain.
Aminoacyl-tRNAs are bound by elongation factor Tu (EF-Tu) in bacteria or eEF1A in eukaryotes and delivered to the ribosomal A site. The anticodon of the tRNA pairs with the mRNA codon, and the amino acid is incorporated into the nascent polypeptide.
Key Genes Involved in GO:0006418 tRNA aminoacylation for protein translation
The following genes encode aminoacyl-tRNA synthetases and related factors that are central to tRNA aminoacylation for protein translation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AARS1 | Alanyl-tRNA synthetase | Mutations cause Charcot-Marie-Tooth disease; target for cancer studies |
| AARS2 | Mitochondrial alanyl-tRNA synthetase | Mutations linked to mitochondrial cardiomyopathy |
| CARS1 | Cysteinyl-tRNA synthetase | Implicated in neurodevelopmental disorders |
| DARS1 | Aspartyl-tRNA synthetase | Mutations cause hypomyelination with brainstem and spinal cord involvement |
| DARS2 | Mitochondrial aspartyl-tRNA synthetase | Mutations cause leukoencephalopathy with brainstem and spinal cord involvement |
| EPRS1 | Glutamyl-prolyl-tRNA synthetase | Component of the multi-synthetase complex; linked to immune response |
| GARS1 | Glycyl-tRNA synthetase | Mutations cause Charcot-Marie-Tooth disease type 2D |
| HARS1 | Histidyl-tRNA synthetase | Mutations cause Usher syndrome and neuropathy |
| IARS1 | Isoleucyl-tRNA synthetase | Mutations linked to growth retardation and neuropathy |
| KARS1 | Lysyl-tRNA synthetase | Mutations cause Charcot-Marie-Tooth disease and deafness |
| LARS1 | Leucyl-tRNA synthetase | Mutations cause infantile liver failure syndrome |
| MARS1 | Methionyl-tRNA synthetase | Mutations cause interstitial lung and liver disease |
| NARS1 | Asparaginyl-tRNA synthetase | Mutations linked to neurodevelopmental disorders |
| RARS1 | Arginyl-tRNA synthetase | Mutations cause hypomyelinating leukodystrophy |
| SARS1 | Seryl-tRNA synthetase | Mutations linked to neurodevelopmental disorders |
| VARS1 | Valyl-tRNA synthetase | Mutations cause microcephaly and neuropathy |
| YARS1 | Tyrosyl-tRNA synthetase | Mutations cause Charcot-Marie-Tooth disease and cancer links |
How Is tRNA aminoacylation for protein translation Regulated?
tRNA aminoacylation is regulated at multiple levels to match protein synthesis demand with amino acid availability. The mTORC1 pathway promotes translation by phosphorylating downstream effectors and influencing ARS expression and activity. Additionally, ARSs can be regulated by post-translational modifications and interactions within the multi-synthetase complex, which modulates their catalytic efficiency and non-canonical functions. In response to amino acid starvation, the integrated stress response (ISR) can inhibit global translation, indirectly affecting aminoacylation demand.
tRNA aminoacylation for protein translation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GARS1 | Charcot-Marie-Tooth disease type 2D | Knock-in mouse model with GARS1 mutation |
| DARS2 | Leukoencephalopathy with brainstem and spinal cord involvement | Patient-derived iPSCs or knockout cell lines |
| AARS2 | Mitochondrial cardiomyopathy | Knockout zebrafish or mouse models |
| YARS1 | Charcot-Marie-Tooth disease and cancer | Overexpression and knockout cell lines |
| METTL1 | Oncogenic transformation | Knockout and overexpression in cancer cell lines |
Cancer
Dysregulation of tRNA aminoacylation contributes to oncogenic transformation. For example, METTL1, a tRNA methyltransferase, was shown to have a methyltransferase-independent role in promoting tRNA aminoacylation and oncogenic transformation, linking aminoacylation to cancer progression. ARSs are also overexpressed in various cancers and are considered potential therapeutic targets.
Neurological Disorders
Mutations in aminoacyl-tRNA synthetases cause a spectrum of neurological diseases, including Charcot-Marie-Tooth disease, hypomyelinating leukodystrophies, and neurodevelopmental disorders. These mutations often impair aminoacylation activity or lead to toxic gain-of-function effects.
Mitochondrial Diseases
Mitochondrial ARSs are essential for mitochondrial translation. Mutations in genes such as DARS2 and AARS2 cause severe mitochondrial diseases, including leukoencephalopathy and cardiomyopathy, highlighting the importance of aminoacylation in mitochondrial function.
From tRNA aminoacylation for protein translation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ARS function impair translation? | CRISPR knockout of specific ARS in cell lines |
| How do disease-associated mutations affect aminoacylation? | Point mutation knock-in via CRISPR |
| Can a tagged ARS be used to study localization? | Knock-in of fluorescent or epitope tag |
| Does overexpression of an ARS drive oncogenesis? | CRISPR overexpression models |
| What is the impact of ARS mutations on mitochondrial function? | Mitochondrial ARS knockout in cell lines |
| Can genetic code expansion be achieved with engineered ARS/tRNA pairs? | Knock-in of orthogonal synthetase/tRNA |
How to Study the tRNA aminoacylation for protein translation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Spectrophotometric assay | ARS activity and kinetics | Enzyme characterization and inhibitor screening |
| tRNA-Seq | Aminoacylation levels of tRNAs | Global analysis of charging status |
| CRISPR knockout screen | Gene essentiality and interactions | Identify regulators of aminoacylation |
| Ribo-seq | Translation efficiency and ribosome occupancy | Assess impact of aminoacylation on translation |
| Proteomics | Protein expression and modifications | Study ARS interactions and post-translational modifications |
| Imaging | Subcellular localization of ARSs | Visualize mitochondrial and cytoplasmic ARSs |
| In vitro aminoacylation | Direct charging of tRNA | Test engineered synthetases for noncanonical amino acids |
Spectrophotometric Assays
Spectrophotometric assays monitor tRNA aminoacylation by measuring the formation of aminoacyl-tRNA or the hydrolysis of ATP. These assays are widely used to determine ARS activity and kinetics.
tRNA-Seq for Aminoacylation Measurement
tRNA-Seq is a robust method for measuring aminoacylation levels in cells. It involves selective oxidation and biotinylation of uncharged tRNAs, followed by sequencing to quantify charged versus uncharged tRNA pools.
Genetic Screens and CRISPR Libraries
CRISPR-based knockout libraries can be used to screen for genes involved in tRNA aminoacylation, identifying essential ARSs and modifiers. These screens help uncover genetic interactions and pathways that regulate aminoacylation.
Structural Biology and Modeling
X-ray crystallography and cryo-EM provide detailed structures of ARSs in complex with tRNA and substrates, revealing the molecular basis of aminoacylation and editing. These structures guide drug design and engineering of orthogonal pairs.
How CRISPR Can Be Used to Study GO:0006418 tRNA aminoacylation for protein translation
Knockout
CRISPR knockout of aminoacyl-tRNA synthetase genes can reveal their essentiality and impact on translation. For example, knocking out a specific ARS in cell lines leads to reduced charging of its cognate tRNA and subsequent translation defects, providing insights into its role in cellular physiology.
Point Mutation
Introducing disease-associated point mutations into ARS genes via CRISPR allows researchers to model the functional consequences of these mutations. This approach helps dissect the molecular mechanisms of ARS-related diseases and test potential therapies.
Knock-in
Knock-in of tags or reporters into ARS genes enables live-cell imaging and biochemical purification. For instance, fluorescent tagging of an ARS can reveal its subcellular localization and dynamics during stress.
Overexpression
CRISPR activation or cDNA overexpression of ARSs can model their upregulation in cancer and study oncogenic transformation. Overexpression of METTL1, for example, promotes tRNA aminoacylation and transformation, linking this process to cancer.
How EDITGENE Supports tRNA aminoacylation for protein translation Research
Researchers studying tRNA aminoacylation for protein translation-related genes often need to determine whether a candidate gene is causally involved in translation regulation, disease, or drug response. EDITGENE provides comprehensive CRISPR-based services to create precise cellular models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for tRNA aminoacylation for protein translation research.
Frequently Asked Questions About tRNA aminoacylation for protein translation
What is tRNA aminoacylation for protein translation?
It is the process of attaching an amino acid to its corresponding tRNA via an ester bond, forming aminoacyl-tRNA for use in protein synthesis.
What genes are involved in tRNA aminoacylation for protein translation?
Genes encoding aminoacyl-tRNA synthetases such as AARS1, GARS1, MARS1, and others, as well as auxiliary factors [3,6].
Why is tRNA aminoacylation important?
It ensures accurate translation of the genetic code and is essential for cell viability; defects cause diseases like Charcot-Marie-Tooth disease.
How is tRNA aminoacylation regulated?
It is regulated by nutrient signaling pathways like mTOR, post-translational modifications of ARSs, and the integrated stress response.
What diseases are linked to tRNA aminoacylation defects?
Neurological disorders, mitochondrial diseases, and cancer [1,6].
What methods are used to study tRNA aminoacylation?
Spectrophotometric assays, tRNA-Seq, CRISPR screens, and structural biology [7,8].
Can tRNA aminoacylation be targeted for therapy?
Yes, ARSs are targets for antibiotics and cancer therapeutics.
What is the role of aminoacyl-tRNA synthetases in cancer?
They can be overexpressed and promote oncogenic transformation, making them potential drug targets [1,2].
How does CRISPR help study tRNA aminoacylation?
CRISPR enables knockout, knock-in, and point mutation models to dissect gene function in this process.
What is the difference between cytoplasmic and mitochondrial tRNA aminoacylation?
They occur in different compartments with distinct ARS enzymes, but both are essential for translation.
Conclusion
tRNA aminoacylation for protein translation (GO:0006418) is a cornerstone of molecular biology, ensuring the fidelity of protein synthesis. Its dysregulation is implicated in a wide range of diseases, from cancer to neurodegeneration, making it a vibrant area of research. Advances in CRISPR technology and analytical methods continue to illuminate the mechanisms and therapeutic potential of this essential process [3,6].
References
- 1. Ali RH et al.. 2025. A methyltransferase-independent role for METTL1 in tRNA aminoacylation and oncogenic transformation.. Mol Cell 85(5):948-961.e11 PMID: 39892392
- 2. Ho JM et al.. 2018. Drugging tRNA aminoacylation.. RNA Biol 15(4-5):667-677 PMID: 29345185
- 3. Rubio Gomez MA et al.. 2020. Aminoacyl-tRNA synthetases.. RNA 26(8):910-936 PMID: 32303649
- 4. Giegé R et al.. 2023. The tRNA identity landscape for aminoacylation and beyond.. Nucleic Acids Res 51(4):1528-1570 PMID: 36744444
- 5. Wang L et al.. 2001. Expanding the genetic code of Escherichia coli.. Science 292(5516):498-500 PMID: 11313494
- 6. Tijaro-Bulla S et al.. 2023. Physiological and engineered tRNA aminoacylation.. Wiley Interdiscip Rev RNA 14(5):e1789 PMID: 37042417
- 7. First EA et al.. 2017. Spectrophotometric assays for monitoring tRNA aminoacylation and aminoacyl-tRNA hydrolysis reactions.. Methods 113:3-12 PMID: 27780756
- 8. Davidsen K et al.. 2024. A robust method for measuring aminoacylation through tRNA-Seq.. Elife 12 PMID: 39076160
